Churg-Strauss syndrome (patient information): Difference between revisions

Jump to navigation Jump to search
Line 55: Line 55:


==Treatment Options==
==Treatment Options==
* Your doctor may suggest treatment with glucocorticoids (such as prednisone) which are given along with other medicines that slow down the immune response. Medicines used to treat [[eosinophilic granulomatosis with polyangiitis]] include:
* Your doctor may suggest treatment with glucocorticoids (eg, predisone) and immunosuppressants that slow down the immune response.  
** Prednisone
* Medicines used to treat [[eosinophilic granulomatosis with polyangiitis]] include:
** Cyclophosphamide (Cytoxan)
** [[Prednisone]]
** Azathioprine (Imuran)
** [[Cyclophosphamide]]
** Methotrexate
** [[Azathioprine]]
** These medicines may cause serious side effects. You should carefully discuss your treatment plan with your doctor. Other medicines may be prescribed, including:
** [[Methotrexate]]
** Bisphosphonate (Fosamax) to prevent bone loss caused by prednisone
** [[Rituximab]]
** Folic acid or folinic acid (leucovorin) -- if you are taking methotrexate
** Interferon alpha
** Trimethoprim/sulfamethoxazole to prevent lung infections
* These medicines may cause serious side effects. You should carefully discuss your treatment plan with your doctor. Other medicines may be prescribed, including:
** [[Bisphosphonate]]:  Prevent bone loss caused by [[prednisone]]
** [[Folic Acid|Folic acid]]: If you are taking [[methotrexate]]
** [[Sulfamethoxazole-Trimethoprim|Trimethoprim/sulfamethoxazole]]: Lung infections
* Some patients may be considered for [[Surgery|surgical therapy]] to relieve symptoms of persistent [[Rhinosinusitis|sinusitis]] and [[Hearing impairment|hearing loss]].
* Some patients may be considered for [[Surgery|surgical therapy]] to relieve symptoms of persistent [[Rhinosinusitis|sinusitis]] and [[Hearing impairment|hearing loss]].


Line 71: Line 74:


==What to expect (Outlook/Prognosis)?==
==What to expect (Outlook/Prognosis)?==
Without treatment, people with this disease can die within a few months.
* Without treatment, people with [[eosinophilic granulomatosis with polyangiitis]] can die within a few months.


With treatment, the outlook for most patients is good. Studies have shown that most people who receive corticosteroids and cyclophosphamide get much better.
* With treatment, the outlook for most patients is good.
* Studies have shown that most people who receive and [[cyclophosphamide]] are doing much better. However, the [[disease]] relapses are common.


==Possible Complications==
==Possible Complications==
Line 82: Line 86:
** [[Pericardial effusion]]
** [[Pericardial effusion]]
** [[Myocardial infarction]]
** [[Myocardial infarction]]
** [[Cardiac tamponade]]
** [[Congestive heart failure]]
* [[Lung|'''Lung''']]:
* [[Lung|'''Lung''']]:
** [[Pleural effusion]]
** [[Pleural effusion]]
** [[Pulmonary hypertension]]
** [[Pulmonary hypertension]]
** Alveolar hemorrhage
** [[Status asthmaticus]]
** [[Status asthmaticus]]
* [[Kidney|'''Kidney''']]:
* [[Kidney|'''Kidney''']]:

Revision as of 19:40, 12 April 2018

Churg-Strauss syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Churg-Strauss syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome (patient information) On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome (patient information)

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome (patient information)

CDC on Churg-Strauss syndrome (patient information)

Churg-Strauss syndrome (patient information) in the news

Blogs on Churg-Strauss syndrome (patient information)

Directions to Hospitals Treating Churg-Strauss syndrome

Risk calculators and risk factors for Churg-Strauss syndrome (patient information)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Eosinophilic granulomatosis with polyangiitis previously called Churg-Strauss syndrome involves primarily small and medium sized blood vessels resulting in vessel inflammation. The exact cause of the disease is not known. However, various environmental factors, allergensgenetics, and drugs may play a role in triggering disease process by activating different types of white blood cells. The disease is characterized by the presence of asthma, peripheral eosinophiliarhinosinusitistingling and numbness of hands and feet (peripheral neuropathy) and multiple organ involvements including skinGI tract, and kidney.

What are the symptoms of Churg-Strauss syndrome

Symptoms of eosinophilic granulomatosis with polyangiitis typically develops through three phases, include prodromal phase, eosinophilic phase, and vasculitis phase. Although these phases cannot be clinically distinguishable.

What causes Churg-Strauss syndrome?

There are no established causes for eosinophilic granulomatosis with polyangiitis. However, various allergensinfectionsvaccinations and drugs may act as a triggering agents, and are responsible for developing disease. Genetics may also play a role.

Who is at highest risk?

Diagnosis

When to seek urgent medical care?

You should see the doctor if you experience any of the following:

The above symptoms may also present in association with other diseases, but they have to be evaluated properly by medical professional.

Treatment Options

Where to find medical care for Churg-Strauss syndrome

Prevention

What to expect (Outlook/Prognosis)?

  • With treatment, the outlook for most patients is good.
  • Studies have shown that most people who receive and cyclophosphamide are doing much better. However, the disease relapses are common.

Possible Complications

Without treatment, eosinophilic granulomatosis with polyangiitis can result in the following complications.

Sources

References

Template:WH Template:WS